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Shared Human/
Rabbit Ligands for 
Rabbit Hemorrhagic 
Disease Virus
To the Editor: Rabbit 
hemorrhagic disease virus (RHDV) 
is a calicivirus of the genus Lagovirus 
that causes epidemics of an acute 
disease and mortality rates of 50%–
90% among rabbits. The disease, 
which was fi rst described in 1984, is 
characterized by hemorrhagic lesions, 
mainly affecting the liver and lungs 
24–72 h after infection (1).
Similar to human caliciviruses 
of the genus Norovirus, RHDV 
binds to histo-blood group antigens 
(HBGAs), and we recently showed 
that HBGAs serve as attachment 
factors (ligands) that facilitate 
RHDV infection (2). HBGAs are 
polymorphic carbohydrate structures 
representing terminally exposed 
portions of larger glycans linked 
to proteins or glycolipids. In many 
vertebrate species, they are mainly 
expressed on epithelial surfaces. 
Because phylogenetic conservation 
of receptors is a major risk factor for 
cross-species transmission (3), we 
analyzed the ability of RHDV strains 
to recognize human HBGAs expressed 
on epithelia.
We obtained 38 saliva samples 
from healthy persons with ABO, 
Secretor, and Lewis phenotypes, and 
we selected confi rmed FUT2 (secretor) 
and FUT3 (Lewis) genotypes (4) to 
include ABO, secretor, and Lewis 
phenotypic diversity. Binding capacity 
of 6 RHDV strains representative of 
virus diversity (2) was tested against 
human saliva samples by using a 
method similar to that reported for 
human norovirus (5).
In brief, saliva samples diluted 
1:1,000 or B type 2 bovine serum 
albumin–conjugated tetrasaccharide 
(positive control) were coated on 
ELISA plates. After blocking with 
milk diluted in phosphate-buffered 
saline, RHDV strains isolated from 
whole liver extracts of infected 
animals were incubated on coated 
plates at dilutions corresponding to 1 × 
109 genome copies (0.2 μg/mL capsid 
protein equivalent) as determined 
by Nyström et al. (2). Monoclonal 
antibody 2G3, biotinylated anti-mouse 
IgG, and peroxidase-conjugated 
avidin were used for RHDV detection; 
3,3′,5,5′-tetramethylbenzidine was 
used as a substrate; and optical density 
values at 450 nm were measured (2).
Binding to the B type 2 epitope 
was observed for all 6 strains (online 
Technical Appendix Figure, panel A, 
wwwnc.cdc/gov/EID/pdfs/11-1402-
Techapp.pdf). Human saliva samples 
were recognized by 5 of 6 RHDV 
strains. Only G6, an RHDV antigenic 
variant also known as RHDVa (6), did 
not show binding to saliva. Strains G1 
and G2 showed preferential binding 
to saliva from B secretors over that 
from O secretors, and A secretors were 
poorly recognized. Better recognition 
of A secretor saliva was obtained 
with the G3 strain. The G4 and G5 
strains showed a clear preference for 
A secretors over B and O secretors, 
which indicated a shift in specifi city 
toward recognition of the A antigen 
from the H and B antigens, as reported 
(2). None of the strains recognized 
nonsecretor saliva, which showed 
that binding to human saliva required 
A, B, or H motifs. This fi nding was 
confi rmed by drastically decreased 
binding after removal of A, B, and 
H epitopes from secretor saliva by 
treatment with specifi c glycosidases. 
There was no relationship with the 
Lewis status.
To determine if human epithelial 
cells were recognized by RHDV, 
binding of the G3 strain to human 
tissue sections was assessed. Human 
trachea, lung, and gastroduodenal 
junction samples obtained from 
organ donors (before current French 
restrictions of December 1988) were 
used to prepare tissue microarrays. 
Tissues from 18 persons were used 
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and represented the following 
phenotypes: O secretor Lewis+ (n 
= 8), A secretor Lewis+ (n = 3), B 
secretor Lewis+ (n = 2), O secretor 
Lewis– (n = 1), and O nonsecretor 
Lewis+ (n = 4). Deparafi nated and 
endogen peroxidase–blocked sections 
were incubated overnight at 4°C with 
the G3 strain from an infected liver 
extract at a concentration of 2 × 109 
genome copies/mL.
Binding was detected by using 
monoclonal antibody 2G3 against 
RHDV, biotinylated anti-mouse IgG, 
horseradish peroxidase–conjugated 
avidin, and 3-amino-9-ethylcarbazole 
substrate with hemalum counter-
staining, as described (2). Staining 
of epithelial cells of stomach or 
trachea of secretors, but not those 
of nonsecretors, was observed. This 
fi nding indicated that attachment 
factors for RHDV are present on 
human cells that constitute potential 
points of entry for RHDV (online 
Technical Appendix Figure, panels 
B–E).
Attachment to HBGAs of human 
calicivirus strains represents a fi rst 
step of the infection process (7). 
In this study, we have shown that 
cross-species recognition of HBGAs 
in cells that may be likely points of 
entry of RHDV into human cells. 
RHDV infection has been shown to 
be rabbit specifi c (8), which indicates 
that other molecular elements not 
shared by rabbits and other mammals 
restrict its host range. Nevertheless, 
RHDV RNA was recently isolated 
from sympatric wild small mammals, 
which suggested that the species range 
of RHDV may not be as limited as 
previously believed (9). In addition, 
recent phylogenetic analysis showed 
that caliciviruses exhibit high levels 
of host switching (10). Therefore, 
surveillance of RHDV and studies 
to decipher molecular mechanisms 
involved in its extreme pathogenicity 
are warranted.
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